Autopsy case of CD4-/CD8- cutaneous T-cell lymphoma presenting disseminated pagetoid reticulosis with aggressive granulomatous invasion to the lungs and pancreas

被引:10
作者
Shiozawa, E
Shiokawa, A
Shibata, M
Nakada, T
Yamochi-Onizuka, T
Saito, B
Takaba, E
Iijima, M
Takimoto, M
Ota, H
机构
[1] Showa Univ, Sch Med, Dept Pathol 2, Shinagawa Ku, Tokyo 1428555, Japan
[2] Showa Univ, Sch Med, Dept Dermatol, Tokyo 1428555, Japan
[3] Showa Univ, No Yokohama Hosp, Dept Pathol, Kanagawa, Japan
关键词
CD4(-)/CD8(-) phenotype; cutaneous T-cell lymphoma; dissemination; pagetoid reticulosis;
D O I
10.1111/j.1440-1827.2005.01785.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Pagetoid reticulosis is a rare cutaneous T-cell lymphoma with striking epidermotropism similar to that present in Paget's disease. There are two forms of pagetoid reticulosis: localized and disseminated. Reported herein is an autopsy case of disseminated pagetoid reticulosis with CD4(-)/CD8(-) phenotype T cells and massive invasion of the lungs and pancreas. The abnormal cells in the epidermis expressed a protein derived from a rearranged T-cell receptor beta gene, and this feature was used to confirm the monoclonality of these cells by polymerase chain reaction. At present, the World Health Organization (WHO) classification system considers pagetoid reticulosis to be an indolent form of primary cutaneous T-cell lymphoma and a variant of mycosis fungoides/Sezary syndrome with prominent epidermotropism. Some differences have been observed between pagetoid reticulosis and mycosis fungoides in terms of clinical course, tumor cell phenotype, and genetic findings; and these differences are highlighted in the present case. The relation between disseminated pagetoid reticulosis, CD4(-)/CD8(-) cutaneous T-cell lymphoma, and gammadelta T-cell lymphoma, including whether pagetoid reticulosis is a variant of mycosis fungoides, remains unclear.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 41 条
  • [31] Activated-cytotoxic TCRαβ+CD4+peripheral T-cell lymphoma with hypodermal localization: Case report of a lymphoproliferative disorder probably evolved from the CD4+cytotoxic T-cell subpopulation
    Tomasini, Dario M.
    Serio, Giovanni
    Landoni, Carlo
    Appio, Lorena
    Crivelli, Filippo
    Bregni, Marco
    JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (03) : 280 - 285
  • [32] Primary cutaneous CD8+cytotoxic T-cell lymphoma of the face with intraoral involvement, resulting in facial nerve palsy after chemotherapy
    Travassos, Daphine Caxias
    Silveira, Heitor Albergoni
    Silva, Evanio Vilela
    Panucci, Beatriz Zamboni Martins
    da Silva Filho, Nilson Coelho
    Silva, Paula Verona Ragusa
    Bufalino, Andreia
    Leon, Jorge Esquiche
    JOURNAL OF CUTANEOUS PATHOLOGY, 2022, 49 (06) : 560 - 564
  • [33] RECIPROCAL MODULATION OF CIRCULATING CD4+CD25+bright T CELLS INDUCED BY EXTRACORPOREAL PHOTOCHEMOTHERAPY IN CUTANEOUS T-CELL LYMPHOMA AND CHRONIC GRAFT-VERSUS-HOST-DISEASE PATIENTS
    Quaglino, P.
    Comessatti, A.
    Ponti, R.
    Peroni, A.
    Mola, F.
    Fierro, M. T.
    Savoia, P.
    Novelli, M.
    Bernengo, M. G.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (02) : 353 - 362
  • [34] Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma
    Blumel, Edda
    Willerslev-Olsen, Andreas
    Gluud, Maria
    Lindahl, Lise M.
    Fredholm, Simon
    Nastasi, Claudia
    Krejsgaard, Thorbjorn
    Surewaard, Bas G. J.
    Koralov, Sergei B.
    Hu, Tengpeng
    Persson, Jenny L.
    Bonefeld, Charlotte Menne
    Geisler, Carsten
    Iversen, Lars
    Becker, Juergen C.
    Andersen, Mads Hald
    Woetmann, Anders
    Buus, Terkild Brink
    Odum, Niels
    ONCOIMMUNOLOGY, 2019, 8 (11):
  • [35] BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines
    Hiroaki Kamijo
    Makoto Sugaya
    Naomi Takahashi
    Tomonori Oka
    Tomomitsu Miyagaki
    Yoshihide Asano
    Shinichi Sato
    Archives of Dermatological Research, 2017, 309 : 491 - 497
  • [36] BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines
    Kamijo, Hiroaki
    Sugaya, Makoto
    Takahashi, Naomi
    Oka, Tomonori
    Miyagaki, Tomomitsu
    Asano, Yoshihide
    Sato, Shinichi
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2017, 309 (06) : 491 - 497
  • [37] Primary Cutaneous CD4+ Small-/Medium-Sized Pleomorphic T-Cell Lymphoma: A Cutaneous Nodular Proliferation of Pleomorphic T Lymphocytes of Undetermined Significance? A Study of 136 Cases
    Beltraminelli, Helmut
    Leinweber, Bernd
    Kerl, Helmut
    Cerroni, Lorenzo
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2009, 31 (04) : 317 - 322
  • [38] Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: A series of 10 adult and pediatric patients and review of the literature
    Baum, Christian L.
    Link, Brian K.
    Neppalli, Vishala T.
    Swick, Brian L.
    Liu, Vincent
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (04) : 739 - 748
  • [39] C-C chemokine receptor 4 expression in CD8+cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment
    Geller, Shamir
    Hollmann, Travis J.
    Horwitz, Steven M.
    Myskowski, Patricia L.
    Pulitzer, Melissa
    HISTOPATHOLOGY, 2020, 76 (02) : 222 - 232
  • [40] Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder: The first-reported Latin-American case with response to doxycycline
    Escanilla, Claudio
    Guavita Falla, Piedad Marcela
    Cevallos, Carolina
    Avalos Jobet, Nicolas
    Bobadilla Bruneau, Francisco
    CLINICAL CASE REPORTS, 2019, 7 (12): : 2405 - 2409